Drug Profile
Ethinylestradiol/norelgestromin
Alternative Names: AP-1081; Contraceptive ATD™ Gel; Ethinylestradiol/norelgestromin transdermal - Antares PharmaLatest Information Update: 26 May 2022
Price :
$50
*
At a glance
- Originator Antares Pharma
- Class Alkylated estrogenic steroids; Hormonal contraceptives; Norpregnatrienes
- Mechanism of Action Estrogen receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Pregnancy
Most Recent Events
- 24 May 2022 Antares Pharma has been acquired by Halozyme Therapeutics
- 08 Apr 2005 Preclinical trials in Contraception/Pregnancy (Prevention) in USA (Transdermal)